Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

JAK inhibitors show promise in treating difficult skin diseases.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Nilotinib can cause keratosis pilaris, a skin condition.

People with PCOS have higher levels of PAI-1, which may increase their risk of heart disease and fertility issues.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Pegvaliase effectively reduces blood phenylalanine levels in most PKU patients, but requires personalized plans and good communication to manage side effects.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Pegvaliase is recommended for treating adults with phenylketonuria.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The diphosphonate was the most effective at preventing calcification in rats.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Isotretinoin can raise CPK levels, so patients need monitoring, especially before surgery.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

A new type of pachyonychia congenita linked to a specific keratin gene mutation was found in two Pakistani families.

CDK4/6 inhibitors generally maintain quality of life in metastatic breast cancer patients, except for some side effects like diarrhea and hair loss.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

CDK4/6 inhibitors may cause hair loss in breast cancer patients.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.